BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
HIV infection
,
Heart
,
Early pregnancy factor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SHP2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Corpus callosum
Substantia nigra reticulata
Globus pallidum external
Putamen
Medulla
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Lentigo
Noonan's syndrome
Turner syndrome
Anomaly of chromosome X
Hyperpigmentation of skin
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
carbinoxamine
DEFB4A protein, human
tropine
Nefopam
Diterpenes
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR489
MIR200B
PLIN1
BRDT
MIR542
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Protein Tyrosine Phosphatase SHP2 in Macrophages Acts as an Antiatherosclerotic Regulator in Mice.
Ubiquitination of NS1 Confers Differential Adaptation of Zika Virus in Mammalian Hosts and Mosquito …
The NS1 protein of contemporary West African Zika virus potentiates viral replication and reduces in…
Extracellular Vesicles Are Conveyors of the NS1 Toxin during Dengue Virus and Zika Virus Infection.
Dengue NS1 interaction with lipids alters its pathogenic effects on monocyte derived macrophages.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutat…
SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors
SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors
SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung C…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ